- Home
- BFRI vs EFSH Comparison
BFRI vs EFSH Comparison
Compare BFRI & EFSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFRI
- EFSH
- Stock Information
- Founded
- BFRI 1997
- EFSH 1948
- Country
- BFRI United States
- EFSH United States
- Employees
- BFRI N/A
- EFSH N/A
- Industry
- BFRI Biotechnology: Pharmaceutical Preparations
- EFSH Professional Services
- Sector
- BFRI Health Care
- EFSH Consumer Discretionary
- Exchange
- BFRI Nasdaq
- EFSH Nasdaq
- Market Cap
- BFRI 6.2M
- EFSH 5.6M
- IPO Year
- BFRI 2021
- EFSH N/A
- Fundamental
- Price
- BFRI $0.98
- EFSH $0.23
- Analyst Decision
- BFRI Strong Buy
- EFSH
- Analyst Count
- BFRI 1
- EFSH 0
- Target Price
- BFRI $7.00
- EFSH N/A
- AVG Volume (30 Days)
- BFRI 990.2K
- EFSH 3.0M
- Earning Date
- BFRI 11-13-2024
- EFSH 11-19-2024
- Dividend Yield
- BFRI N/A
- EFSH N/A
- EPS Growth
- BFRI N/A
- EFSH N/A
- EPS
- BFRI N/A
- EFSH N/A
- Revenue
- BFRI $35,358,000.00
- EFSH $69,415,140.00
- Revenue This Year
- BFRI $17.69
- EFSH N/A
- Revenue Next Year
- BFRI $19.71
- EFSH N/A
- P/E Ratio
- BFRI N/A
- EFSH N/A
- Revenue Growth
- BFRI 5.17
- EFSH 228.22
- 52 Week Low
- BFRI $0.61
- EFSH $0.20
- 52 Week High
- BFRI $3.90
- EFSH $820.95
- Technical
- Relative Strength Index (RSI)
- BFRI 52.63
- EFSH 39.23
- Support Level
- BFRI $0.94
- EFSH $0.20
- Resistance Level
- BFRI $1.06
- EFSH $0.28
- Average True Range (ATR)
- BFRI 0.12
- EFSH 0.04
- MACD
- BFRI -0.01
- EFSH 0.59
- Stochastic Oscillator
- BFRI 28.89
- EFSH 15.83
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. Its licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Its licensed product is Ameluz, which is a prescription drug approved for use in combination with the RhodoLED lamp series, for PDT (when used together, Ameluz PDT). including the complementary product BF-RhodoLED, and Xepi.
About EFSH 1847 Holdings LLC
1847 Holdings LLC is a diversified holding company. It operates in Four segments: Retail and appliances, Retail and Eyewear, Construction, and Automotive Supplies. The company generates maximum revenue from the Construction segment. The firm, through its subsidiaries, provides a wide range of land application services and sells equipment and parts, primarily to the agricultural, construction, and lawn and garden industries.